Jude Owiredu is currently a PhD candidate at Weill Cornell Medicine, where he is pursuing his doctoral degree in the Biochemistry, Cell and Molecular Biology (BCMB) program. He is currently a member of the Barbieri Lab within the Department of Urology. His academic background includes a Bachelor of Science, work in the Balk lab (2019-2021), and he has established himself as a researcher focused on the intersection of transcription factor biology and oncology.
His scientific interests primarily center on prostate cancer initiation and progression, with a specific emphasis on the role of transcription factor biology. His research investigates how androgen receptor splice variants and canonical androgen response element (ARE) motifs drive metastasis and tumor suppression in castration-resistant prostate cancer. By utilizing advanced molecular biology techniques, Owiredu aims to uncover the transcriptional programs that allow cancer cells to adapt and survive during therapy.
Beyond his laboratory work, he is an advocate for the graduate student experience, encouraging peers to "trust the process" and appreciate the long-term journey of scientific discovery